General

A look at the $50B opportunity reshaping how pharma companies launch, monitor, and defend their brands in the age of […]

Physicians are increasingly asking AI chatbots how to dose drugs, manage contraindications, and choose between therapies. The AI answers. The

How pharmaceutical brands are losing control of patient conversations, clinical narratives, and competitive positioning inside the black box of generative

Drug companies spend billions crafting brand narratives. AI is rewriting them in real time — and most manufacturers have no

How artificial intelligence is tracking, shaping, and sometimes undermining pharmaceutical brand strategy — and what drug companies need to do

A scan of hundreds of real-world questions on DrugChatter reveals a consistent pattern: patients are not just asking what a

A growing share of medication questions aren’t being asked in exam rooms. They’re being typed into search bars and forums

Across DrugChatter’s growing library of patient questions, a clear theme emerges: people are constantly trying to “switch” something in their

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a

There’s a particular genre of drug question that never goes out of style: “What happens if I mess this up?”

There’s a pattern to mass adoption in pharma. First comes clinical data, then prescriber uptake, then—inevitably—the public internet asking the

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic